Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Solid Tumor 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Fulvestrant 64Letrozole 54Paclitaxel 49Trastuzumab 41pembrolizumab 40ribociclib 37Specimen Handling 37palbociclib 36Capecitabine 34Anastrozole 34Carboplatin 33Tamoxifen 32exemestane 30pertuzumab 28abemaciclib 28Magnetic Resonance Spectroscopy 26Cyclophosphamide 26trastuzumab deruxtecan 24Surveys and Questionnaires 21Biopsy 19Radiotherapy 18olaparib 17Blood Specimen Collection 17Standard of Care 16Docetaxel 16Taxes 14Mastectomy, Segmental 14eribulin 13elacestrant 13Methods 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Histocompatibility Testing × 90 days × Clear all
NCT07023822 2026-05-05

WISH, Feasibility of a Factorial Design

The University of Tennessee, Knoxville

Phase NA Completed
18 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡